An Aggressive Transformation to EBV-Positive Hodgkin Lymphoma after Bendamustine-Containing Chemotherapy for Marginal Zone Lymphoma

Hideyuki Nakazawa^1*, Hitoshi Sakai¹, Toru Kawakami¹, Yukio Hirabayashi², Ko Nakazawa³, Naoko Asano⁴, Fumihiro Ishida^1,5 and Kiyoshi Kitano²

¹Division of Hematology, Department of Internal Medicine, School of Medicine, Shinshu University, Matsumoto, Japan

²Department of Hematology, NHO Matsumoto Medical Center, Matsumoto, Japan

³Department of Laboratory Medicine, Department of Laboratory Medicine, Matsumoto, Japan

⁴Department of Molecular Diagnosis, Nagano Prefectural Suzaka Hospital, Suzaka, Japan

⁵Department of Biomedical Laboratory Sciences, Shinshu University School of Medicine, Matsumoto, Japan

^*Corresponding Author: Hideyuki Nakazawa, Division of Hematology, Department of Internal Medicine, School of Medicine, Shinshu University, Matsumoto, Japan, 3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan, Tel: +81-263-37-2634, Fax: +81-263-32-9412 Email: